How Viruses Evolve: Mutation, Variants, and Why Flu Shots Change Every Year

Viruses: Evolution at High Speed

Viruses are the fastest-evolving entities on Earth. With generation times measured in hours, population sizes in the billions within a single infection, and high mutation rates, viruses can evolve dramatically within weeks — adapting to hosts, evading immune responses, and developing drug resistance at speeds impossible for multicellular organisms. Understanding viral evolution is essential for vaccine design, pandemic preparedness, and antiviral drug development.

Mutation: The Engine of Viral Evolution

Evolution requires heritable variation — mutations that can be passed to offspring. Viruses generate this variation through errors in replication. The mutation rate depends critically on the enzyme that copies the viral genome:

• RNA viruses (influenza, HIV, SARS-CoV-2, hepatitis C) use RNA-dependent RNA polymerase, which lacks the proofreading capability of DNA polymerase. Error rate: ~10⁻⁴ per nucleotide per replication — roughly 1 error per genome per replication cycle. This high rate generates enormous diversity rapidly.
• DNA viruses (herpes, poxviruses) use DNA polymerase with proofreading, giving much lower error rates (~10⁻⁸ to 10⁻¹⁰). They evolve more slowly.

In a single infection, an RNA virus may produce 10¹⁰–10¹² viral particles, each potentially carrying different mutations. This creates a "quasispecies" — a swarm of closely related but distinct variants, not a single sequence.

Selection: Which Variants Survive

Mutation generates variation; natural selection determines which variants propagate. In virology, selection comes from:

• Host immunity: Antibodies target specific viral proteins (epitopes). Mutations that change those epitopes allow the virus to escape existing immunity — driving the evolution of new variants.
• Antiviral drugs: Drugs target specific viral proteins. Mutations that reduce drug binding while maintaining function generate drug resistance.
• Cell tropism: Mutations in receptor-binding domains can expand or change which cells and species the virus can infect.
• Transmissibility: Variants that transmit more efficiently spread faster through populations, outcompeting less transmissible variants.

Recombination and Reassortment

In addition to mutation, viruses can exchange genetic material:

• Recombination: Two viral genomes recombine within a co-infected cell, creating hybrid variants. Important in HIV and coronaviruses.
• Reassortment: Segmented RNA viruses (influenza, rotavirus) can exchange entire genome segments. When a cell is co-infected with two different influenza strains, their segments can be packaged in new combinations — producing novel combinations of surface proteins. This is called antigenic shift and is responsible for influenza pandemic emergence (1918, 1957, 1968, 2009 pandemics all involved reassortment).

Influenza: Why Flu Shots Change Every Year

Influenza evolves through two mechanisms:

• Antigenic drift: Gradual accumulation of mutations in hemagglutinin (HA) and neuraminidase (NA) — the surface proteins antibodies target. Over 1–2 seasons, enough mutations accumulate that antibodies from prior infection or vaccination no longer bind well, reducing protection. This requires annual flu vaccine reformulation to match currently circulating strains.
• Antigenic shift: Sudden emergence of a novel HA or NA through reassortment. Because most people have no pre-existing immunity to the new combination, pandemic potential exists.

WHO surveillance tracks circulating strains globally year-round; the February/September WHO meetings select the strains to include in next season's vaccine — a scientific and logistical challenge given the 6-month production timeline.

COVID-19 Variants

SARS-CoV-2 demonstrated how rapidly a novel RNA virus can diversify under population immunity pressure. Major variants of concern (VOC) — Alpha, Beta, Delta, Omicron and its subvariants — each carried multiple mutations in the spike protein that increased transmissibility or immune evasion:

• Delta: Dramatically increased transmissibility (2–3× original strain), becoming the dominant global strain in mid-2021
• Omicron: Unprecedented spike protein mutations (30+), dramatically enhanced immune evasion — reducing vaccine protection against infection substantially while remaining less severe per infection due to changed cellular tropism (upper vs. lower respiratory tract)

COVID-19's evolution illustrated real-time how selection pressure from population immunity drives antigenic evolution — a pattern seen with seasonal coronaviruses for decades and the basis for why COVID boosters will likely be a recurring reality, similar to annual flu shots.